Siklos

Active Ingredient(s): Hydroxyurea
FDA Approved: * December 21, 2017
Pharm Company: * ADDMEDICA SAS
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Siklos Overview

Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera.[1][2] In sickle-cell disease it decreases the number of attacks.[1] It is taken by mouth.[1] Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches.[1][2] There...

Read more Siklos Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Hydroxycarbamide

Recent Siklos Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Hydroxyurea
  • Capsule: 1000mg, 200mg, 250mg, 300mg, 400mg, 500mg
  • Tablet: 1000mg, 100mg, 1gm
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Siklos: (2 results)

Sorted by National Drug Code
  • 71770-100 Siklos 100 mg Oral Tablet, Film Coated by Medunik
  • 71770-120 Siklos 1000 mg Oral Tablet, Film Coated by Medunik

Other drugs which contain Hydroxyurea or a similar ingredient: (4 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA